Exchange: NASDAQ·Updated 07:30 PM EDT

ALMR Earnings

Latest Earnings Results: Q2 '26

Reported: Aug 10

Estimated EPS

-$0.31

Reported EPS

-$0.22

Surprise

+28.54%

Estimated Rev

$25.86M

Reported Rev

$29.4M

Surprise

+13.69%

• Reported GAAP EPS of -$0.22 up 64.52% YoY • Reported revenue of $29.43M up 82.08% YoY • Alamar Biosciences expects full year 2026 revenue to be in the range of $116 million to $120 million, representing growth of 59% at the midpoint of the range compared to 2025.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.21
--
--
N/A
Q2 '26
-$0.31
-$0.22
28.54%
BEAT
Q1 '26
-$1.71
--
--
N/A

Advertisement|Remove ads.